DATE: 2025/04/02
Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial
Sci Transl Med. 2025 Apr 2;17(792):eadi4505. doi: 10.1126/scitranslmed.adi4505. Epub 2025 Apr 2.
AUTHORS: Gomez-Mancilla B, Dürsteler KM, Vogel M, Herdener M, Torrens M, Gálvez BP, Gual A, Corral RM, Kuper EI, Mosca DL, Dumitras S, Pezous N, Berkheimer M, Walker E, Gasparini F, Cha JH, Dolmetsch R.
PMID: 40173260